A recent study finds that the N6-methyladenosine (m6A) modifier METTL3 regulates proliferation and differentiation in myeloid cells and acute myeloid leukemia (AML).
This is a preview of subscription content, log in via an institution to check access.
Katie Vicari/Springer Nature
References
Kwaja, A. et al. Nat. Rev. Dis. Primers 2, 16010 (2016).
Batista, P.J. et al. Cell Stem Cell 15, 707–719 (2014).
Geula, S. et al. Science 347, 1002–1006 (2015).
Li, H.-B. et al. Nature 548, 338–342 (2017).
Vu, L.P. et al. Nat. Med. 23, 1369–1376 (2017).
Batista, P.J. Genomics Proteomics Bioinformatics 15, 154–163 (2017).
Keene, J.D. Nat. Rev. Genet. 8, 533–543 (2007).
Edupuganti, R.R. et al. Nat. Struct. Mol. Biol. 24, 870–878 (2017).
Liu, N. et al. Nature 518, 560–564 (2015).
Spitale, R.C. et al. Nature 519, 486–490 (2015).
Cui, Q. et al. Cell Rep. 18, 2622–2634 (2017).
Zhang, S. et al. Cancer Cell 31, 591–606 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Schmiechen, A., Batista, P. An epitranscriptomic vulnerability in myeloid malignancies. Nat Med 23, 1252–1254 (2017). https://doi.org/10.1038/nm.4435
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4435
- Springer Nature America, Inc.